BIRMINGHAM, Ala., Feb. 14 /PRNewswire-USNewswire/ -- Officials at Southern Research Institute today announced that Wilson Blaine Knight, Ph.D., a former executive with GlaxoSmithKline (GSK), has been named Vice President of its Drug Discovery Division.
(Photo: http://www.newscom.com/cgi-bin/prnh/20080214/DC14244 )
"We are very pleased that Dr. Knight has joined us to lead our very successful drug discovery research program," said John A. "Jack" Secrist, III, Ph.D., president and CEO of Southern Research Institute. "His global pharmaceutical industry experience will be extremely valuable to Southern Research as we expand our service offering to clients worldwide. In addition, Dr. Knight's scientific background is solid, and he has a great appreciation for basic research and how it can be translated into products that prevent and cure diseases."
For the past seven years at GlaxoSmithKline, Dr. Knight has served in a number of roles including Vice President of Non-Clinical Globalization Projects/Preclinical Development and as the Vice President of Strategic Alliances; Vice President of Screening Sciences; and Vice President of Systems Research in the Discovery Research Directorate. In the latter two roles, he was responsible for leading more than 200 scientific staff members in the US, UK, Spain, Italy and Japan in comprehensive compound profiling and integrated lead discovery strategies. While at Glaxo, Dr. Knight was instrumental in placing several compounds into development, particularly in the oncology therapeutic area.
From 1995 - 2000, Dr. Knight served as Director of Molecular
Biochemistry in the Biochemistry Division of Glaxo-Wellcome. He also held
several positions with the Glaxo Research Institute/Glaxo, Inc. from
1992-1995, later becoming head of the Dept. of Biochemistry and Protein
Engineering in the Division of Molecular Sciences. Pr
'/>"/>
| SOURCE Southern Research Institute Copyright©2008 PR Newswire. All rights reserved |